Kieffer Tara Lynn
Chief Product Strategy Officer at ENTA
- Sold, on record
- $158k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Dec 5, 2025
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ENTAENANTA PHARMACEUTICALS INCChief Product Strategy Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ENTANo planDec 5, 2023 2023
Sold 2,125 shares at $9.63 ($20k)
Kieffer Tara Lynn, Sr. VP, New Prod. Strat. & Dev
No 10b5-1 planSold 5.4% of holdings ($379k position)37,260 shares leftFirst sale on recordFiling
- 2 Form 144 notice ENTANoticeJun 17, 2024 +195 days
Filed to sell 7,266 shares ($92k)
Kieffer Tara Lynn, Officer
10b5-1 planFiling
- 3 Form 4 sale ENTARoutineJun 17, 2024 same day
Sold 7,266 shares at $12.33 ($90k)
Kieffer Tara Lynn, Chief Product Strategy Officer
10b5-1 planSold 18.3% of holdings ($488k position)32,341 shares leftFollows a Form 144Filing
- 4 Form 4 sale ENTARoutineDec 6, 2024 +172 days
Sold 2,283 shares at $8.06 ($18k)
Kieffer Tara Lynn, Chief Product Strategy Officer
10b5-1 planSold 7.2% of holdings ($255k position)29,305 shares leftFiling
- 5 Form 4 sale ENTANo planDec 5, 2025 +364 days
Sold 2,106 shares at $14.23 ($30k)
Kieffer Tara Lynn, Chief Product Strategy Officer
No 10b5-1 planSold 6.4% of holdings ($466k position)30,620 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | Dec 5, 2025 | ENTA | Chief Product Strategy Officer | Form 4 sale | 2,106 | $30k | 6.4% | No plan | SEC |
| Dec 6, 2024 | Dec 10, 2024 | ENTA | Chief Product Strategy Officer | Form 4 sale | 2,283 | $18k | 7.2% | Routine | SEC |
| Jun 17, 2024 | Jun 17, 2024 | ENTA | Chief Product Strategy Officer | Form 4 sale | 7,266 | $90k | 18.3% | Routine | SEC |
| Jun 17, 2024 | Jun 17, 2024 | ENTA | Officer | Form 144 notice | 7,266 | $92k | Notice | SEC | |
| Dec 5, 2023 | Dec 6, 2023 | ENTA | Sr. VP, New Prod. Strat. & Dev | Form 4 sale | 2,125 | $20k | 5.4% | No plan | SEC |